Willem E Fibbe
Overview
Explore the profile of Willem E Fibbe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
8038
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perico N, Remuzzi G, Griffin M, Cockwell P, Maxwell A, Casiraghi F, et al.
J Am Soc Nephrol
. 2023 Aug;
34(10):1733-1751.
PMID: 37560967
Significance Statement: Mesenchymal stromal cells (MSCs) may offer a novel therapy for diabetic kidney disease (DKD), although clinical translation of this approach has been limited. The authors present findings from...
2.
Leeneman B, Blommestein H, van Dongen-Leunis A, Algeri M, Fibbe W, Oosten L, et al.
Eur J Haematol
. 2023 May;
111(2):240-246.
PMID: 37137484
Background: Evidence regarding health-related quality of life (HRQoL) in patients with steroid-refractory acute graft-versus-host disease (SR-aGvHD) is lacking. Evaluating HRQoL was a secondary objective of the HOVON 113 MSC trial....
3.
van Halteren A, Suwandi J, Tuit S, Borst J, Laban S, Tsonaka R, et al.
Blood
. 2022 Aug;
141(11):1277-1292.
PMID: 36044666
Acute graft-versus-host disease (aGVHD) is an immune cell‒driven, potentially lethal complication of allogeneic hematopoietic stem cell transplantation affecting diverse organs, including the skin, liver, and gastrointestinal (GI) tract. We applied...
4.
Barnhoorn M, van der Meulen-de Jong A, Schrama E, Plug L, Verspaget H, Fibbe W, et al.
Stem Cells Transl Med
. 2022 Aug;
11(9):932-945.
PMID: 35984079
Locally applied mesenchymal stromal cells (MSCs) have the capacity to promote the healing of perianal fistulas in Crohn's disease (CD) and are under clinical development for the treatment of proctitis...
5.
Hidalgo-Simon A, Fibbe W
Br J Clin Pharmacol
. 2021 Apr;
87(6):2412-2413.
PMID: 33899269
No abstract available.
6.
Reinders M, Groeneweg K, Hendriks S, Bank J, Dreyer G, de Vries A, et al.
Am J Transplant
. 2021 Feb;
21(9):3055-3065.
PMID: 33565206
After renal transplantation, there is a need for immunosuppressive regimens which effectively prevent allograft rejection, while preserving renal function and minimizing side effects. From this perspective, mesenchymal stromal cell (MSC)...
7.
8.
Dreyer G, Groeneweg K, Heidt S, Roelen D, van Pel M, Roelofs H, et al.
Am J Transplant
. 2020 Apr;
20(10):2905-2915.
PMID: 32277568
Mesenchymal stromal cells (MSC) hold promise as a novel immune-modulatory therapy in organ transplantation. First clinical studies have used autologous MSCs; however, the use of allogeneic "off-the-shelf" MSCs is more...
9.
Das R, Roosloot R, van Pel M, Schepers K, Driessen M, Fibbe W, et al.
J Transl Med
. 2019 Jul;
17(1):241.
PMID: 31340829
Background: Cell-based therapies have the potential to become treatment options for many diseases, but efficient scale-out of these therapies has proven to be a major hurdle. Bioreactors can be used...
10.
Chhatta A, Cordes M, Hanegraaf M, Vloemans S, Cupedo T, Cornelissen J, et al.
J Allergy Clin Immunol
. 2019 Jul;
144(5):1416-1419.e7.
PMID: 31323248
No abstract available.